Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost Effectiveness Analysis of Rivaroxaban Compared to Warfarin and Aspirin for Stroke Prevention Atrial Fibrillation (SPAF) in the Indonesian healthcare setting

Published:2019-03-26 Issue:1 Volume:30 Page:74
ISSN:2338-9486
Container-title:Indonesian Journal of Pharmacy
language:
Short-container-title:Indonesian J. Pharm.

Author:

Dwiprahasto Iwan,Kristin Erna,Endarti Dwi,Pinzon Rizaldy Taslim,Yasmina Alfi,Thobari Jarir At,Pratiwi Woro Rukmi,Kartika Yolanda Dyah,Trijayanti Christiana

Publisher

Universitas Gadjah Mada

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacy

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of non-communicable disease prevention in Southeast Asia: a scoping review;Frontiers in Public Health;2023-11-09

2. Methods for Economic Evaluations of Novel Oral Anticoagulants in Patients with Atrial Fibrillation: A Systematic Review;Applied Health Economics and Health Policy;2023-10-29

3. Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Systematic Review of Economic Evaluations;Value in Health Regional Issues;2023-01

4. Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis;BMJ Evidence-Based Medicine;2021-10-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP